Spore.Bio

Spore.Bio

Private
ParisFrontier & Industrial Techhttps://spore.bio/

Last Round

Grant

Jan 8, 2026

Total Funding Raised

$31.3M

Momentum Score

75 /100

Company Overview

Spore.Bio is a biotechnology company that has developed an AI-powered technology for real-time microbiology testing.

Sector

Frontier & Industrial Tech

Verticals

Quality Management, Smart Manufacturing, Biotech Equipment, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

pathogen detectionmicrobiological testingreal-time testingrapid diagnosticsAI diagnosticsfood safety testingfactory floor diagnosticsquality control automationbacterial contaminationsmart manufacturingpharma quality controlindustrial IoTbiotech equipmentcosmetics quality controlproduct recall prevention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spore.Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Spore.Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJan 8, 2026
Series AFeb 19, 2025
Pre SeedDec 12, 2023

Key People

Founding team and executive leadership

Maxime Mistretta

Co-founder CTO

Founding Team

Mohamed Tazi

Co-Founder COO

Founding Team

Amine Raji

Co-Founder CEO

Founding Team

Spore.Bio Investors

Notable investors and investment history

InvestorRounds
LocalGlobeSeries A, Pre Seed
SingularSeries A
EmergingTech VenturesPre Seed
1st Kind by Peugeot FamilySeries A
Better AnglePre Seed
No Label VenturesSeries A, Pre Seed
Google.orgGrant

Spore.Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spore.Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spore.Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range55
Year Founded2023
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.